NeuroVive Pharmaceutical AB Dividend
What is the Dividend of NeuroVive Pharmaceutical AB?
The Dividend of NeuroVive Pharmaceutical AB is N/A
What is the definition of Dividend?
Dividend rate is the amount of dividends per share a company pays its stockholders over a year.
ttm (trailing twelve months)
The dividend rate is the total amount a company pays per share to a shareholders of its stock over a trailing one year. When the amount is calculated to be a ratio, the dividend rate identifies the dividends paid out per share. Dividends are when a company distributes a percentage of their profits to shareholders.
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.